A comparison of treosulfan and carboplatin in patients with ovarian cancer not suitable for treatment with cisplatin.
Phase of Trial: Phase II
Latest Information Update: 21 Apr 2014
At a glance
- Drugs Carboplatin (Primary) ; Treosulfan (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 02 Feb 2012 Planned end date (15 Jul 1998) added as reported by ISRCTN: Current Controlled Trials.
- 02 Feb 2012 Status changed from completed to discontinued as reported by ISRCTN: Current Controlled Trials.
- 30 Nov 2005 New trial record.